Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

[18F]-MNI-659 striatal binding significantly correlates with HD severity

April 3, 2013

SBI Pharmaceuticals' malignant glioma diagnostic approved in Japan

March 28, 2013

Threshold set to acquire Siemen's investigational hypoxia PET imaging agent

March 26, 2013

FDA and EMA set to review Piramal Imaging's marketing applications

March 26, 2013

FDA approves AdreView to evaluate cardiac risk in heart failure patients

March 25, 2013

Guerbet announces FDA approval for Dotarem

March 25, 2013

FDA recategorizes Meridian's illumigene tests for Streptococcus

March 21, 2013

Venaxis enters commercial development agreements for its appendicitis test

March 20, 2013

FDA clears Quidel and Life Technologies products

March 19, 2013

Nanosphere gains clearance in E.U. for Gram-Negative Blood Culture test

March 15, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...